LncRNA MYOSLID was first reported in human VSMC‐selective and serum‐responsive factor/CArG‐dependent lncRNA, which regulates VSMC differentiation through the MKL1 and transforming growth factor‐beta/SMAD pathways.23 We have previously studied the differentially expressed lncRNA in GC from the Cancer RNA‐Seq Nexus database and found that the expression of lncRNA MYOSLID in GC is significantly different and is associated with the survival prognosis of GC.24 However, the mechanism of lncRNA MYOSLID in GC remains elusive. This evidence concerns the gene MYOSLID and cancer.